KRAS and neoplasm: Additionally, KRAS G12D mutation regulates the transcription of key metabolic enzymes such as glutamate dehydrogenase (GLUD1) and aspartate aminotransferase (GOT1) [25,26], enabling tumor cells to meet carbon and nitrogen demands for rapid proliferation and macromolecular synthesis.